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ADHS Forum
Mr. ATOD’s Wild Ride: What Do Alcohol,
Tobacco, and Other Drugs Have in Common?
David T. Courtwright
Abstract. All researchers agree that individuals can become intoxicated by
and dependent on alcohol, tobacco, and other psychoactive drugs. But they
have disagreed over whether, and to what extent, drug pathologies comprise
a unitary medical problem. Most critically, does addiction have a biological
common denominator? Consensus on this question has shifted back and
forth. In the late nineteenth and early twentieth centuries, physicians often
studied and treated various drug addictions together, working under the
“inebriety” paradigm. By the mid-twentieth century the inebriety paradigm
had collapsed. Tobacco and alcohol had split off, both in the medical research
community and in western popular culture. This article argues that neuroscientiﬁc, genetic, epidemiological, and historical evidence helped to reunify
the addiction ﬁeld in the late twentieth century. A new unifying paradigm
emerged, variously called chemical dependency, substance abuse, or simply
ATOD—alcohol, tobacco, and other drugs.

When you write global drug history, you quickly discover
the limits of your knowledge, and you rely on the work of others.
Many of the scholars whose research has guided and inspired me are
present this evening. I ﬁrst want to express my debt to you and my
gratitude for the opportunity to address you. I am truly honored.
My title, “Mr. ATOD’s Wild Ride,” is an anagrammatic play on
a celebrated episode from Kenneth Grahame’s The Wind in the
David T. Courtwright is John A. Delaney Presidential Professor in the Department of
History at the University of North Florida. He delivered “Mr. ATOD’s Wild Ride” on
May 14, 2004, as the Keynote Address of the International Conference on Drugs and
Alcohol in History at Huron University College, London, Ontario.
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Willows. Mr. Toad, you will recall, has a thing for fast machines. He
is, in fact, unable to control himself around them. They “intoxicate
. . . his weak brain.” Disguised as a washerwoman, Toad commandeers a motor car and goes hurtling down the road. When its owner
and chauffeur imprudently try to stop him, he sends the car veering
across the road, smashes into a hedge, and goes ﬂying through the
air.
Mr. Toad’s wild ride has inspired a Monty Python movie and
an amusement-park ride in my home state of Florida. Toad’s ride
has also inspired me by suggesting a metaphor for shifting western
and, more particularly, Anglo-American, attitudes toward ATOD:
alcohol, tobacco, and other drugs. In the last century those attitudes
have, like Toad’s car, veered sharply. They have gone from a
tendency to see ATOD and their pathologies as linked phenomena,
then to a tendency to see them as separate phenomena, then, in the
last thirty years, to see them again as linked. I’ve sketched these
shifting attitudes toward ATOD as a pendular timeline (Figure 1).
It’s not an exact timeline, for most of the events depicted occurred
over many years, rather than during a single year. But it makes the
point. Consensus on this question has lurched from one side of
history’s road to the other and then back again.
I use the words “tendency” and “consensus.” I don’t think that
all experts shared these attitudes at any given point in time, or that
the swings of opinion occurred without dissent. What I propose
is a sketch of “governing ideas.” Governing ideas are “cognitive
bundles” of related concepts that have had “considerable intellectual appeal and at some point succeeded in capturing the attention,
imagination, and actions of the broad population” (Gerstein and
Harwood 1990, 42). Specialists framed problems in certain ways,
and their views percolated into popular consciousness and language.
In the 1960s continental drift and plate tectonics triumphed as
governing ideas in geology, and before long school children were
getting watered-down versions in their earth science lessons. New
ideas about the nature and management of compulsive alcohol
and other drug use spread in comparable fashion—with, as Sarah
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Figure 1. Governing Ideas about Alcohol, Tobacco, and Other Drugs

Tracy points out, input from patients and their families along the
way (Tracy 2005).
So what were the governing ideas about psychoactive substances?
In the late nineteenth century, the key medical concept, at least in
Britain and most of North America, was inebriety. Many physi-
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cians who treated alcoholics and narcotic addicts held that these
conditions were manifestations of a more general mental disorder
called “inebriety.” The Keeley Institute, a large treatment franchise,
advertised that the “person addicted to liquor or drugs is a victim
of a ravishing disease,” which may nevertheless be successfully
treated “by the famous Keeley Treatment” (Keeley Institute 1921,
emphasis added). The treatment regimen for residential Keeley
patients—who might be dependent on alcohol, or narcotics, or
both—required abstention from tobacco and even caffeinated
beverages, understood as insalubrious habits likely to trigger
relapse (White 1998, 55).
The inebriety theory drew on three other popular nineteenthcentury medical ideas. These were neurasthenia, or nervous
weakness; diathesis, or constitutional predisposition to chronic
disease; and degeneration, or transmission of morbid deviations
across generations. Thomas Crothers, a representative ﬁgure, taught
that alcohol and other drugs had pathological effects on the nervous
system. The effects varied. Those suffering from neurasthenia, such
as exhausted “brain workers,” were particularly susceptible. Also
susceptible were those born with a nervous diathesis. Whether
the vulnerability was environmental or constitutional—in our
terms, whether it was due to stress, genes, or both—alcohol and
other drugs left a permanent pathological impression on inebriates’ nerves. The repeated administration of a drug intensiﬁed this
impression into a “morbid craving,” the heedless, self-destructive
pursuit of the substance that seemed the common denominator of
all inebriate behavior (Crothers 1902).
Once acquired, the trait of inebriety could be passed on as degenerate constitutional tendencies. The process was often one of sinister
transmogriﬁcation. The drunkard’s child might be an opium addict,
his grandchild an epileptic, his great grandchild a congenital idiot.
Though inebriate degeneration might assume many forms, its ﬁnal
end was always ruin. It was crucial, therefore, to keep the young
from acquiring inebriate habits, for their sake and for posterity’s.
Drugs were literally “germ poisons” that threatened the “race” by
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corrupting sperm and ova. Caleb Saleeby, a prominent English
eugenicist and opponent of both tobacco and alcohol, went so far
as to argue that alcoholics should be prevented from procreating
(Armstrong 2003, 27-42; Woiak 1998).
Other temperance advocates concentrated on preventing drug
use from spreading within, rather than across, generations. They
made tobacco a particular target, for tobacco often led to drink and
other drugs. The most trenchant of the early “gateway” theorists
was Charles Towns, a lay addiction specialist. Except for a few
women, Towns wrote, every alcoholic and addict he treated had a
history of excessive tobacco use. Smoking magniﬁed any personal
predisposition toward inebriety, “because the action of tobacco
makes it normal . . . to feel the need of stimulation.” Tobacco’s irritating effects could be blunted by alcohol, on which the smoker in
turn became dependent. Then came narcotics to allay hangover and
other effects of drinking. “Cigarettes, drink, opium is the logical
and regular series” (Towns 1915, 153).
Towns set forth his views in Habits That Handicap (1915), a slender
little book that was perhaps the most prescient work about ATOD
linkages to appear in the early twentieth century. Towns was an
intuitive sociologist who saw that smoking was socially conducive
to other forms of addiction. Boys sought out the back rooms of
pool halls and saloons to smoke in secrecy, and there they also
learned to gamble and drink. Better-educated men who refrained
until they entered college found themselves “out of it” if they didn’t
light up. Sociability was tobacco’s most seductive attraction, and
its social utility made it that much harder to quit. Worse, tobacco’s
use scandalized others and tempted them to follow the same path
to intoxication. “The very openness and permissibility of the vice,”
Towns decided, made tobacco the worst of the drug habits (Towns
1915, 172).
When Towns wrote those words the ﬁrst ATOD paradigm
was near—actually, just past—its zenith. As John Burnham and
Caroline Acker have shown, beliefs about the pathological links
among drugs and other vices had yielded practical political conse-
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quences in the broad-gauge progressive campaign against the urban
“vice constellation.” The same reformers who went after narcotics
and alcohol often tried to suppress cigarettes, prostitution, pornography, and gambling. Essentially, they understood vice as a package
deal (Burnham 1993; Acker 2002).
Even in the 1910s, however, forces were emerging that would spell
the end of the ﬁrst inebriety movement. In fact, by the late 1930s, the
idea of biosocial linkages among alcohol, tobacco, and other drugs
had all but disappeared. True, it persisted in otherwise disparate
groups that shared an unremitting ideological hostility to all
psychoactive drugs. Nazis, Mormons, and Evangelical Protestants
come to mind. Total sobriety makes for strange bedfellows. But
in both western medicine and in western popular culture, alcohol
and tobacco effectively split off from other drugs, to the point that
the ordinary understanding of the word “drugs” came to exclude,
rather than include, these substances. Anyone who asked North
American high school students in the 1940s what “drugs” meant
would have been told they had something to do with hospitals or
dope ﬁends. Why did this happen?
The collapse of the unifying inebriety theory is a good place to
begin. Brieﬂy, its proponents never delivered the scientiﬁc goods.
They never showed, at the level of cellular pathology, the common
mechanism by which drugs caused lasting neurological damage
in susceptible persons, or caused such symptoms as withdrawal
and craving. The few speciﬁc hypotheses, such as Ernest Bishop’s
antitoxin analogy, were falsiﬁed. No one ever discovered the
mechanism by which alcohol and other drugs damaged germ plasm.
The Lysenko episode aside, belief in Lamarckian ideas collapsed.
Western researchers abandoned the assumption that acquired traits
could be passed on to offspring. The Nazi horrors and abuses such
as involuntary sterilization gave eugenics a bad name. Researchers
quit generalizing about alcohol as a “race poison,” or generalizing
much about races at all.
What midcentury researchers did do, with the support of both
Alcoholics Anonymous and the alcoholic beverage industry, was to
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focus on alcoholism. Howard Haggard and E. M. Jellinek’s widely
read 1942 book, Alcohol Explored, exempliﬁed the new approach.
Alcoholism was still a disease, to be sure, but a speciﬁc disease
manifest in a minority of users who could not control their drinking.
Alcohol itself was not inherently toxic. The authors found no
evidence that alcohol damaged offspring, either through heredity
or teratogenesis. Indeed, for the majority of drinkers, alcohol was
merely a harmless “social condiment.” The old inebriety view of
alcohol—in Norman Kerr’s words, that it was a “poisonous narcotic
beverage”—now seemed passé (Roizen 2004; Haggard and Jellinek
1942, 12, 208; Kerr 1887, 2).
The widespread social use of alcohol by physicians and their
spouses could only have made these new views more congenial. The
same may be said of tobacco. The now-infamous Camel claim, that
doctors smoked Camels more than any other brand, was false. But
the deeper premise—that doctors smoked a lot of cigarettes, at least
before the ﬁrst big cancer scare in the 1950s—was true. Personal use
tended to blind physicians and researchers to the harms of tobacco
and to its links to other patterns of drug use.
They weren’t alone. As millions of ordinary men and women
took up cigarettes, the idea that smoking necessarily led to intoxicating drugs faded. Many of the new smokers were patriotic
veterans of the Great War, and they had received their cigarettes
from reputable organizations like the Red Cross (Tate 1999).
Airplane pilots even dropped cigarettes to doughboys in advanced
posts. A few years ago, working in the Library of Congress, I found
a gouache drawing with the unlikely title “Colonel Sir Valtravers
Plantagenet gladly accepts a light, during a slight lull in the barrage,
from a private in the Benin Riﬂes” (Figure 2). I proposed the illustration for Forces of Habit, only to have one of my editors veto it.
She said it played on racial stereotypes. It certainly did, but that’s
why I thought it worked. It made my point that cigarettes had transcended the conventional social boundaries of race and class. Only
the barrier of gender remained, and that gave way in the 1920s and
1930s, thanks to clever advertising and the inﬂuence of the movies.
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Figure 2. Gouache drawing in the Library of Congress: “Colonel Sir
Valtravers Plantagenet gladly accepts a light, during a slight lull in the
barrage, from a private in the Benin Riﬂes.”

In the late 1930s, 1940s, and 1950s, cigarette smoking among
adults became so widespread as to be unremarkable, unexception-

Mr. ATOD’s Wild Ride

113

able, socially invisible. Smoking paraphernalia spread everywhere.
Ash trays sprouted on bistro tables and soda-fountain counter tops,
cigarette lighters appeared on car dash boards, and, if you wanted
to make a statement, you could even buy your own ring-cigarette
holder. Matchbooks, which doubled as a convenient form of advertising, were the most common sort of paraphernalia. Their covers
show how culturally Janus-faced smoking had become. Some of
them already nod back in the direction of the underworld, the
adult world of risqué jokes and taverns and extra-marital sex. But
there’s also the shining upperworld of modernity: nationalism, fast
transportation, electriﬁed communication, and consumer conveniences. Smoking is up-to-date and linked to two other kinds of
licit drugs, alcoholic and caffeinated beverages. Matchcovers even
pitched products designed to ameliorate the consequences of
smoking, such as cough drops—an aspect of a broad phenomenon
that economists call “externalities” and I call “problem proﬁts.”
Both the masses and elites smoked. Elite smoking habits were so
well known that cartoonists could use them as shorthand, identifying
Winston Churchill by his long cigar, FDR by his cigarette holder,
and Douglas MacArthur by his corncob pipe. Such personal use
of tobacco had nothing to do with “real” drugs. Indeed, pamphlets
at the Lexington Narcotic Hospital told new patients where to buy
their smokes. Clouds of smoke hung over AA meetings. By contrast,
the Keeley Institute had refused to accept cigarette smokers. The
late-nineteenth-century view was that they had slipped into the use
of alcohol and narcotics easily, and that, while they smoked cigarettes, they could not abstain from other drugs.
The decoupling of alcohol and tobacco from other drugs was no
accident. It was at least partly the result of a deliberate campaign
by powerful and ﬁscally important industries, which spent millions
on advertising and public relations to promote and defend their
products. These industries had a huge advantage. Ethical pharmaceutical manufacturers couldn’t advertise drugs like narcotics or
stimulants, except within relatively narrow professional medical
circles. Folk or bohemian drugs like marijuana spread by word of
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mouth. Virtually the only advertising they generated was ofﬁcial
warnings aimed at discouraging their use. Makers of alcohol and
tobacco, however, were free to present their products as innocent
and salubrious, and to do so to a mass audience. Guinness famously
reduced the message to a slogan: “Guinness is good for you.”
Abetted by the movies, alcohol and tobacco ads played up
themes of youth, glamor, athleticism, and conviviality. True, the
manufacturers could never fully escape or suppress the evidence
of their products’ toxicity and addictive potential. But they could
hire public relations experts to counter unwelcome news. Hill and
Knowlton, America’s leading public relations ﬁrm, worked for both
the Licensed Beverages Industries, Inc., and the cigarette manufacturers. Hill and Knowlton managed the Tobacco Industry Research
Committee, a public relations operation intended to assuage public
anxieties by raising doubts about the cancer link and fostering the
impression that the industry was actively investigating any potential
health problems. The British industry created a comparable organization. It challenged purely statistical studies and called attention
to the industry’s funding of lung-cancer research. The implicit
message: if there’s something bad in cigarettes, the scientists in the
white coats will ﬁnd it and take it out, so relax and carry on smoking
(Courtwright 2005).
Of course, there were plenty of honest researchers in the midtwentieth-century, researchers who operated independently of the
tobacco and alcoholic beverage industries. But they all faced the
problem of information glut. Another, quotidian reason that the
ﬁrst ATOD paradigm unraveled was specialization. To cope with
the literature explosion, researchers had to concentrate on one
drug, or one aspect of one drug. I suspect everyone here has come
up against this problem. When I began my dissertation on opiate
addiction, I found an international bibliography, The Pharmacology
of the Opium Alkaloids (Krueger, Eddy, and Sumwalt, 1943), that
was full of clinical, epidemiological, and pharmacological material.
Too full: there were nearly 10,000 entries. I remember thinking,
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“They’ve got to be kidding.” Any notion of studying more than one
type of drug in one country quickly departed.
I sank my particular posthole in the mid-1970s and dug in it
contentedly for some time. Looking back over thirty years, I’d say
the biggest surprise has been the rebirth of inebriety. It doesn’t go
by that name, or any single name. It’s been called chemical dependency, substance abuse, and ATOD abuse, among other terms.
But there’s no mistaking its presence. Bill White, a clinician and
historian, said it best in Slaying the Dragon. “For most of the 20th
century,” White wrote, “no conceptual umbrella existed to help the
ﬁeld understand and intervene in the destructive use of all psychoactive drugs. The most seminal event in the modern era of addiction
treatment was the reformulation of terms analogous to the earlier
concept of inebriety.” Researchers and clinicians rethought the
addiction experience, emphasizing its commonalities and looking
for integrated theories and treatment approaches. The same
conceptual shift, White argued, was linked to the “culture’s more
temperate relationship with alcohol and its growing rejection of
tobacco” (White 1998, 287-88).
So attitudes toward ATOD have swerved backed to the other
side of the road. The big increases in youthful and polydrug abuse
undoubtedly had much to do with this switch. So did the growing
western cultural awareness of, and aversion to, health risks of any
variety. But I want to highlight three “internalist” factors: discoveries in neuroscience, genetics, and new epidemiological ﬁndings.
Since the 1960s, scientists have worked out, in increasingly reﬁned
detail, how psychoactive drugs affected the mesolimbic dopamine
system. This is the neural reward pathway that originates in the
ventral tegmental area at the base of the brain. From this region
the neurotransmitter dopamine carries messages forward to the
nucleus accumbens, a key pleasure center beneath the frontal cortex.
Experiments on animals that have been taught to self-administer
drugs have shown a sure-ﬁre method for eliminating addiction: just
destroy this system. Of course, there are minor drawbacks, like loss
of interest in food. That’s why drug addiction is so stubborn and
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insidious. It represents, at least on one level, the chemical hijacking
of the brain’s most basic and ancient system of reward and motivation.
There’s more to the story than a single neural pathway. Drug
administration also sends messages to the amygdala and hippocampus, which are important for forming memories and cues
associated with craving and relapse. It’s also true that drugs work
in different ways. Opiates and alcohol stimulate dopamine production directly, while cocaine blocks its reuptake. But the bottom line,
to quote a recent literature review, is “different drugs, same ultimate
effect” (Nestler and Malenka 2004, 84). That goes for licit and illicit
drugs, and sometimes for licit and illicit drug treatment. Naltrexone,
an antagonist that blocks opioid receptors and which has been used
to treat narcotic addicts, has shown promising results in preventing
craving and relapse among alcoholics (Rawson et al. 2000). Though
the degree of Naltrexone’s therapeutic beneﬁt is still under investigation, and though it may not help the severest alcoholics (e.g.,
Krystal et al. 2001), the ﬁndings do suggest that at least some of
the opioid receptors are involved in both types of addiction. Also
intriguing is the fact that PET brain scans of compulsive gamblers
shown slot machines look very similar to those of cocaine addicts
shown white lines on a mirror. Compulsive gambling and drug
addiction have many symptomatic parallels, and there is a good
deal of comorbidity: heavy gamblers are more likely to be ATOD
users, and vice versa (Petry 2002).
That’s not to say that all forms of addiction can be reduced to a
single neural pathway, or that drug use can be understood apart
from its social and cultural context. When critics (e.g., Satel 2002)
accuse the National Institute on Drug Abuse of being obsessed with
the “chronic relapsing brain disease model,” to the exclusion of
other approaches, they make a fair point. Even Alan Leshner, the
former head of NIDA who did so much to popularize the neurological model, wrote that “addiction is not just a brain disease. It
is a brain disease for which the social contexts in which it has both
developed and is expressed are critically important” (Leshner 1997,
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46). Still, one does not have to be a biological reductionist to grasp
the historical signiﬁcance of this research trend or to understand
how it reinforces the idea that psychoactive drugs have more in
common than was once thought. The progressives had a point.
Vices are linked.
The predisposition toward vice may also have a genetic basis, if not
necessarily a Lamarckian one based on our ancestors’ poisonously
altered germ plasm or otherwise wickedly acquired characteristics.
“Several twin studies,” to quote a recent JAMA review, have shown
“signiﬁcantly higher rates of dependence among twins than among
nontwin siblings and higher rates among monozygotic [identical]
than dizygotic [nonidentical] twins.” Heritability measures have
been estimated at 0.34 for men dependent on heroin, 0.55 for men
dependent on alcohol, 0.52 for women dependent on marijuana,
and 0.61 for men and women who are regular cigarette smokers
(McLellan et al. 2001). The inebriety theorists’ hunch, that individual
reactions to alcohol, tobacco, and other drugs vary, depending on
innate neurological susceptibility and family history, have apparently been borne out for several different substances. Some people
are disposed to ﬁnd certain kinds of drug use more rewarding, or
less toxic, or both. Addictive predispositions may overlap. Studies
have shown that those with a genetic predisposition for alcohol
dependence are also more likely to have problems with pathological gambling (Petry 2002, 185).
It is possible that the correlations are due, not so much to neurological susceptibility per se, but to personality traits that are also
partially inherited. Children, especially male children, who lack
self-control and future orientation, who are impulsive, insensitive to others, and less intelligent, are more likely to experiment
with drugs. In fact, this same constellation of traits predicts a wide
range of illegal behaviors (Gottfredson and Hirschi 1990). Loutish
thrill-seekers will end up with more ATOD problems for the same
reason they end up with more jail time for smash-and-grab thefts
and joyriding in stolen cars. Personality traits increase the odds
of forbidden experimentation, and experimentation increases the
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odds of (indeed, is a prerequisite for) long-term conditions like
addiction.
Having said this, I should add that I’ve long had reservations
about the concept of an “addictive personality,” whether deﬁned in
terms of neurological susceptibility or broader antisocial behavior.
If personality is so important, why were most American opiate
users middle-aged, middle-class females in the nineteenth century
and younger, lower class-men in the twentieth? Or why were they
once mostly white and Asian and, then, within the space of two
or three decades in the mid-twentieth century, mostly black and
Hispanic? Were the addictive personality traits “jumping genes”
that hopped from one group to another? (Courtwright 2001a, 6,
152-55). Obviously, speciﬁc social circumstances—what doctors
prescribed, which immigrants were moving into drug-infested
slums—mattered a great deal. One might even say that it is the
historian’s indispensable task to point out what those speciﬁc
circumstances were, and how they changed over time. That said,
the question of inherited vulnerability has clearly reemerged in the
addiction research ﬁeld; it has important implications for etiology,
prevention, destigmatization, and treatment; and it has reinforced
the idea that a range of compulsive behaviors may have common
biological elements.1
The third ﬁeld that has contributed to the rebirth of the ATOD
paradigm has been epidemiology. Even allowing for some beneﬁcial cardiovascular effects from moderate wine drinking,
statisticians documented, with increasing precision, the elevated
risks of accidents when drinking, and the risks of chronic disease
for heavy drinkers. The more one drank, the greater the risks—a
dose-response ﬁnding central to the emergence of the alcohol
public-health paradigm in the mid-1970s (Roizen 2004; Room
2004). The smoking data were even more damning. The relentless accumulation of health evidence, and the related economic
evidence of heavier health-care costs, undercut the efforts of alcohol
and tobacco companies to portray their products as benign nondrugs. It also explains why these same companies have increasingly
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sought to exploit markets in developing countries, where government regulations are fewer and consumers tend to be less wary.
In the mid-1970s, Denise Kandel and others put the gateway
theory on a much ﬁrmer epidemiological basis. They emphasized
the risk of advancing from licit to illicit drugs. Not all smokers or
drinkers did so, but their odds of progression were far higher than
abstainers’—a ﬁnding that held up in France, Israel, and Japan as
well. As a recent RAND study shows, adolescent smokers were at
especially high risk (Kandel 2002; Ellickson 2002). The same study
showed early smoking to be an excellent predictor of subsequent
social problems. When the politician and novelist Jeffrey Archer
was sent to Belmarsh prison following his 2001 perjury conviction,
practically the ﬁrst thing he noticed was the ubiquity of smoking.
It took only a few strip searches before it dawned on him that the
inmates, especially the repeat offenders, were also heavily involved
in the illicit drug culture (Archer 2003).
The process by which young smokers moved on to other drugs
involved three types of causes—social, learning, and neurochemical.
None was necessary or sufﬁcient, but all increased the likelihood of
other drug use. Socially, “enabling factors” played a key role. These
were the inﬂuences Charles Towns had in mind when he described
boys lighting up in the pool hall. Adolescent smokers were more
likely to be part of peer groups in which alcohol and other drugs
were available. They were more likely to become curious about
them, to observe how they were used, and to receive praise if they
tried them for themselves. Ditto other problem behavior, such as
petty theft or skipping school.
Learning also played a part. Smoking is an acquired skill,
something neither intuitive nor pleasant on ﬁrst trial. By learning to
inhale tobacco smoke, individuals acquired the behavior necessary
for consuming marijuana and other smokable drugs. Because
underage smoking was illegal, adolescent tobacco users also learned
to develop masking behaviors that served to hide forbidden drug
use.
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Then there is the effect of tobacco itself. Smokers have lower levels
of monoamine oxidase-B, the enzyme responsible for breaking
down dopamine in the brain. They can sustain higher levels of
dopamine for longer periods of time, particularly if they continue
smoking. More dopamine means more pleasure: tobacco works
synergistically with alcohol, cannabis, cocaine, and narcotics to
provide a sustained high. Hence alcohol and other drug users tend to
smoke more heavily. The reverse is also true. Alcohol, a depressant,
mitigates some of the adverse effects of smoking, such as increased
heart rate. And alcohol activates nicotine-metabolizing enzymes,
which makes it necessary to consume more tobacco to achieve the
accustomed effect (Courtwright and Courtwright, forthcoming).2
In brief, the neuroscientiﬁc and epidemiological studies suggest
that drug consumption is synergistic and crosses licit-illicit lines.
I found that out for myself when I began, in the opening chapters
of Forces of Habit, to describe when various drugs had become
important commodities. We have all been taught that description
is easier than analysis. I found the opposite to be true. The analytic
chapters—how medical drugs caught on in popular culture,
why drugs were ideal products, how drugs ﬁnanced empires and
exploited colonial labor, why elites ﬁnally imposed restrictions—
turned out to be much easier to write. The biggest challenge was
describing the globalization of drugs, a process I called the “conﬂuence of the world’s psychoactive resources” (Courtwright 2001b).
I thought I’d tackle one drug at a time. I’d describe the spread of
alcoholic beverages, then tobacco, then caffeinated beverages—“the
big three”—then move on to opiates, cannabis, coca products, and
synthetics. Try as I might to keep my drug histories compartmentalized, they kept sloshing over onto one another. “Conﬂuence” really
is le mot juste. The Chinese, for example, learned to smoke tobacco,
then tobacco mixed with opium, then reﬁned opium. When early
modern European sailors went on liberty, pipe in one hand and
drink in the other, they instructed natives in the art of smoking and
drinking. They taught that these two novel practices went together.
(As, neurochemically, they in fact do.) I discovered that early
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modern European coffee houses were seldom simply coffee houses.
Patrons could purchase all sorts of psychoactive products, from
chocolates to exotic liqueurs. They could also smoke, which was
good for business, because, we now know, smokers metabolized
caffeine much faster than nonsmokers. I also found that complex,
overlapping patterns of consumption had developed in Europe’s
many colonies. In 1945, when Ho Chi Minh declared Vietnamese
independence, he condemned the French for foisting opium and
alcohol on his people. I suppose he didn’t add tobacco to the list
because he himself was an inveterate smoker.
At the deepest level of historical connection, one might say at
the point where economic substructure meets the reptile brain, the
common denominator of globalized nonmedical drug use was the
rise of limbic capitalism. By that I mean the reorientation of capitalist enterprise from basic services and durable goods to the more
proﬁtable business of providing transient but habitual pleasures,
whether drugs or pornography or gambling or even sweet and fatty
foods. In global terms limbic capitalism ﬁrst became important in
the age of transoceanic empire building. Were it not for the trade
in sugar, tobacco, tea, and opium, there never would have been a
British Empire, with all that entailed for modern history. Limbic
capitalism has become even more conspicuous and lucrative
in our own advanced (if that is the word) consumer societies.
Entrepreneurs exploit evolved drives and then provide the goods
and services to cope with the damage. Alcohol sells aspirin,
cigarettes sell nicotine patches, sugar sells insulin, heroin sells
Naltrexone, which costs addicted patients between $100 and $150
a month (Rawson et al. 2000). A recent book, Investing in Vice,
concludes that the best, most recession-proof ﬁnancial strategy is
to buy a portfolio of “sin stocks,” taking advantage of their relatively inﬂexible demand curves (Ahrens 2004). I would “double
down” the bet by adding stocks of the companies that clean up after
the sin companies. Logically, the demand curves for the two sorts
of products are correlated.
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I can’t explore all the ramiﬁcations of limbic capitalism. But
I have tried to show how biological, genetic, epidemiological,
and historical evidence has given momentum and credibility
to the revitalized ATOD paradigm. That doesn’t guarantee its
permanent or universal triumph. In particular, alcohol may resist
the trend. The alcoholic beverage industry has money, inﬂuence,
and an argument—moderate consumption is healthful—that may
continue to win privileges for its product. Time will tell. Invite me
back thirty years hence, and I’ll tell you whether Mr. ATOD’s car
has swerved back to the other side of the road.
University of North Florida
dcourtwr@unf.edu
Notes
1. For reasons of time, I omitted the section on genetics during the original talk.
2. The relationship between nicotine and caffeine is complex, but researchers
have shown that rats chronically exposed to caffeine self-administer nicotine
at higher-than-control levels. Compared to nonsmokers, heavy smokers prefer
more heavily caffeinated beverages, e.g, coffee rather than tea. Other drugs
shown to increase nicotine consumption in animals include pentobarbital,
amphetamine, methadone, and heroin (Courtwright and Courtwright, forthcoming).

References
Acker, C. 2002. Creating the American junkie: Addiction research in the classic
era of narcotic control. Baltimore: Johns Hopkins University Press.
Ahrens, D. 2004. Investing in vice: The recession-proof portfolio of booze, bets,
bombs, and butts. New York: St. Martin’s Press.
Archer, J. 2003. A prison diary. New York: St. Martin’s Press.
Armstrong, E. M. 2003. Conceiving risk, bearing responsibility: Fetal Alcohol
Syndrome and the diagnosis of moral disorder. Baltimore: Johns Hopkins
University Press.
Burnham, J. C. 1993. Bad habits: Drinking, smoking, taking drugs, gambling,
sexual misbehavior, and swearing in American history. New York: New York
University Press.

Mr. ATOD’s Wild Ride

123

Courtwright, A. M., and D. T. Courtwright. Forthcoming. “Alcohol, tobacco,
and other drugs.” Tobacco, ed. J. Goodman et al. Charles Scribner’s Sons.
Courtwright, D. T. 2001a. Dark paradise: A history of opiate addiction in America.
Cambridge, Mass.: Harvard University Press.
Courtwright, D. T. 2001b. Forces of habit: Drugs and the making of the modern
world. Cambridge, Mass.: Harvard University Press.
Courtwright, D. T. 2005. “‘Carry on smoking’: Public relations and advertising
strategies of American and British tobacco companies since 1950.” Business
History 47: 421-32.
Crothers, T. D. 1902. Morphinism and narcomanias from other drugs: Their
etiology, treatment, and medicolegal relations. Philadelphia: W. B. Saunders.
Ellickson, P. et al. 2002. “Does early smoking signal later problems?” RAND
Research Highlights. http://www.rand.org/publications/RB/RB4547/.
Gerstein, D. R., and H. J. Harwood, eds. 1990. Treating drugs problems, vol. 1:
A study of the evolution, effectiveness, and ﬁnancing of public and private drug
treatment systems. Washington, D.C.: National Academy Press.
Gottfredson, M. and T. Hirschi. 1990. A general theory of crime. Stanford:
Stanford University Press.
Haggard, H. W., and E. M. Jellinek. 1942. Alcohol explored. Garden City, N.Y.:
Doubleday.
Kandel, D. B., ed. 2002. Stages and pathways of drug involvement: Examining the
gateway hypothesis. Cambridge: Cambridge University Press.
Keeley Institute. 1921. “Liquor is the worst handicap in every game of life.”
[advertising sewing kit] Advertising Ephemera Collection, Special Collections
Library, Duke University.
Kerr, N. 1887. Wines: Scriptural and ecclesiastical, 2nd ed. London: National
Temperance Publication Depot.
Krueger, H., N. B. Eddy, and M. Sumwalt. 1943. The pharmacology of the opium
alkaloids, part 2, supplement no. 165 to the Public Health Reports. Washington,
D.C.: United States Public Health Service.
Krystal, J. H. et al. 2001. “Naltrexone in the treatment of alcohol dependence.”
New England Journal of Medicine 345: 1734-39.
Leshner, A. I. 1997. “Addiction is a brain disease, and it matters.” Science 278:
45-47.
McClellan, A.T. et al. 2001. “Drug dependence, a chronic mental illness.” JAMA:
The Journal of the American Medical Association 284: 1689-95.
Nestler, E. J. and R. C. Malenka. 2004. “The addicted brain.” Scientiﬁc American
290, no. 3 (March): 78-85.
Petry, N. M. 2002. “How treatments for pathological gambling can be informed
by treatments for substance use disorders.” Experimental and Clinical
Psychopharmacology 10: 184-92.

124

The Social History of Alcohol and Drugs 20 (2005)

Rawson, R.A. et al. 2000. “Addiction pharmacotherapy 2000: New options, new
challenges.” Journal of Psychoactive Drugs 32: 371-78.
Roizen, R. 2004. “How does the nation’s ‘alcohol problem’ change from era
to era? Stalking the social logic of problem-deﬁnition transformations since
Repeal.” Pp. 61-87 in Altering American consciousness: The history of alcohol
and drug use in the United States, 1800-2000, ed. S. W. Tracy and C. J. Acker.
Amherst: University of Massachusetts Press.
Room, R. 2004. “Alcohol and harm reduction, then and now.” Paper at the
International Conference on Drugs and Alcohol in History, Huron University
College, London, Ontario, May 14, 2004.
Satel, S. 2002. “Is drug addiction a brain disease?” Pp. 55-63 in One Hundred
Years of Heroin, ed. D. Musto et al. Westport, Conn.: Auburn House.
Tate, C. 1999. Cigarette wars: The triumph of “the little white slaver.” New York:
Oxford University Press.
Towns, C. B. 1915. Habits that handicap: The menace of opium, alcohol, and
tobacco, and the remedy. New York: Century.
Tracy, Sarah. 2005. Alcoholism in America: From Reconstruction to Prohibition.
Baltimore: Johns Hopkins University Press.
White, William. 1998. Slaying the Dragon: The History of Addiction Treatment
and Recovery in America. Bloomington, Ill.: Chestnut Health Systems/
Lighthouse Institute.
Woiak, Joanne. 1998. “Drunkenness, degeneration, and eugenics in Britain:
Anti-alcohol reform in Caleb Saleeby’s program of preventive eugenics.”
Paper presented at the American Association for the History of Medicine,
Toronto.

The Social History of Alcohol and Drugs 20 (2005): 138-40.

Addiction Science, History, and the ATOD
Paradigm: A Reply to Hasso Spode, Ian Tyrrell,
and James Mills
David T. Courtwright
Hasso Spode and Ian Tyrrell are right to point out that, in a global
perspective, the debate over addiction began earlier and assumed
more complex forms than indicated in my sketch. It is true too that
ideas about addiction were “culturally lagged”—a useful phrase—
and that the question of ATOD unity begged another issue, namely,
where addiction was existentially located. So, yes, the situation a
century ago was messier than the inebriety paradigm alone would
indicate. Hence my circumspection in limiting the discussion
to Britain and North America, places where the uniﬁed inebriety
concept temporarily dominated medical opinion.
“Medical opinion” was not, as James Mills reminds us, solely the
domain of physicians and scientists. My own lay example, Charles
Towns, was a salesman who overcame initial skepticism from the
medical establishment and who became, for a time, a respected
ﬁgure in the treatment community. In Britain and North America,
however, physicians like Norman Kerr or Thomas Crothers did
most of the technical, etiological writing on drugs and the nervous
system. Ultimately, it was their failure to create a testable empirical
basis for the uniﬁed inebriety theory, to advance beyond the
vague nineteenth-century concepts of neurasthenia, diathesis, and
degeneration, that made the concept vulnerable to scientiﬁc and
corporate counterattack in the mid-twentieth century.
Today the revitalized ATOD paradigm extends well beyond the
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Anglo-American world. It has gone global, as has the scientiﬁc
enterprise itself. On-line journals carry the latest discoveries
about neural pathways, receptors, genetic predispositions, drug
synergisms, and gateway epidemiology to researchers and public
health ofﬁcials around the world. Tyrrell captured the spirit of
my essay when he suggested that historians can apply these same
medical-scientiﬁc insights to past patterns of drug use, while
avoiding biological reductionism by showing the play of cultural,
geographic, and social forces.
All three commentators note that I emphasized medical research
discoveries in explaining the rise of the new ATOD paradigm. One
reason for doing so is that the lack of biological evidence was a key
reason why the old inebriety paradigm collapsed. Nineteenth- and
early twentieth-century observers saw that addictive behaviors
were like one another in important ways, such as compulsive
use, withdrawal symptoms, craving, and relapse. Until the 1970s,
however, no one could make neurochemical sense of why different
substances produced similar intoxicating and addictive effects. That
was the essential breakthrough, though external factors like growing
concern over health risks or corporate malfeasance prepared the
cultural soil onto which the seed of scientiﬁc insight fell.
When I wrote the lecture I knew that drug historians preferred the
cultural soil to the scientiﬁc seed. Another reason for highlighting
scientiﬁc advances was to bring them to the attention of an inﬂuential
scholarly audience that seemed to be getting too comfortable in its
social-constructionist ways. James Mills counters that “so much of
what has gone before as authoritative data has, in fact, simply been
morality or prejudice dressed up with the ribbons of science.” Fair
enough. But it is also fair to say that we now know more, and in
more ﬁne detail, about how various drugs actually affect the brain
than we did in the Victorian era. There is progress in science, and
that progress can be liberating. For too long drug historians have
been like transportation historians writing separate monographs
on cars, trucks, and motorcycles without knowing how internal
combustion engines worked, or why they burned hydrocarbon
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fuels and generated pollution. Suspicion of scientiﬁc arrogance
and imperialism ought not to prevent anyone from the selective
appropriation of research insights, especially those that illuminate
the common or synergistic features of drug action. My subversive
advice: break history’s last taboo. Take a hit of neuroscience. Just
don’t get addicted.
Tyrrell asks where the line on drugs should be drawn. My rule
of thumb is to include any psychoactive substance that stimulates
the mesolimbic dopamine system, the primitive neural substrate of
pleasure and motivation. Thus cocaine and caffeine are both drugs,
though one is good deal stronger than the other. Sugar is a special
case. I don’t consider sugar a drug per se, but it has often been made
into a drug (alcohol) or used to sweeten drug preparations such as
chewing tobacco or tea. A spoonful of sugar makes the alkaloid go
down.
If drug history evolves toward the broader study of compulsive
behaviors, such as gambling or even certain types of eating, I would
be neither surprised nor perturbed. Cheese may not be “morphine
on a cracker,” as one activist has claimed, but we should remain
open-minded about where research on the brain’s pleasure centers
will lead. Social history is about making connections. Medical
science keeps suggesting new connections. Is it, for example, just
a cultural coincidence that games of chance have long ﬂourished
in taverns, or that Las Vegas runs on booze, or that the Koran
prohibits both alcohol and gambling? I don’t know the answer. I
do know that posing such questions will enrich our ﬁeld, and align
us with researchers who are expanding the boundaries of other
disciplines.
University of North Florida
dcourtwr@unf.edu

